Whilst reduced caloric intake is part of the therapeutic goal, it is essential that the calories consumed are nutrient-dense, so that the body continues to receive adequate protein, vitamins, and minerals throughout treatment
Why Employers Are Paying Attention GLP-1 medications are increasingly associated with managing obesity, Type 2 diabetes, cardiovascular risk and related chronic conditions, all major drivers of employer healthcare costs
The most recent report: Eagle Analytical Services is an independent FDA-registered laboratory, A2LA accredited to ISO 17025, based in Houston, Texas
The gradual escalation protocol for both medications is specifically designed to minimise side effects and tolerability
& Feil, R
Procedures Participants received subcutaneous semaglutide 2.4 mg or placebo once-weekly for 104 weeks, in addition to standard behavioral intervention, followed by 7 weeks without treatment